{
  "items": [
    {
      "title": "Argenx: The Magic May Be Already Priced In",
      "description": "Argenx is a hold due to limited catalysts in 2025, a rich valuation and clinical risk around label expansion. Read more about ARGX stock here.",
      "published_utc": "2025-03-24T21:56:32",
      "source": "SeekingAlpha",
      "url": "https://finnhub.io/api/news?id=0d2cee3752538f8b5993d1f1bf07d4f8c09a0f5d431d22d4713bb2b764bffc41",
      "category": "company",
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2184219690/image_2184219690.jpg?io=getty-c-w1536",
      "related_symbols": [
        "JNJ"
      ],
      "api_source": "finnhub_company",
      "id": 133352325,
      "datetime": 1742824592
    },
    {
      "title": "Is Johnson & Johnson (JNJ) The Best Healthcare Dividend Stock to Invest in?",
      "description": "We recently published a list of 13 Best Healthcare Dividend Stocks to Invest in. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best healthcare dividend stocks to invest in. The US healthcare sector has been at the forefront since the emergence of COVID-19 in [â€¦]",
      "published_utc": "2025-03-24T21:14:42",
      "source": "Yahoo",
      "url": "https://finnhub.io/api/news?id=2e696d75aa13938bebb71467a9fdd8322227b428ca9a26275ad8054f31541b77",
      "category": "company",
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related_symbols": [
        "JNJ"
      ],
      "api_source": "finnhub_company",
      "id": 133337819,
      "datetime": 1742822082
    }
  ]
}